These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 24005472

  • 1. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.
    Zhou L, Liu G, Jia Z, Yang KT, Sun Y, Kakizoe Y, Liu M, Zhou S, Chen R, Yang B, Yang T.
    Am J Physiol Renal Physiol; 2013 Nov 15; 305(10):F1491-7. PubMed ID: 24005472
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
    Song J, Knepper MA, Hu X, Verbalis JG, Ecelbarger CA.
    J Pharmacol Exp Ther; 2004 Feb 15; 308(2):426-33. PubMed ID: 14593089
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure.
    Goltsman I, Wang X, Lavallie ER, Diblasio-Smith EA, Ovcharenko E, Hoffman A, Abassi Z, Feuerstein GZ, Winaver J.
    Circ Heart Fail; 2011 May 15; 4(3):345-54. PubMed ID: 21398416
    [Abstract] [Full Text] [Related]

  • 4. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
    Tiwari S, Blasi ER, Heyen JR, McHarg AD, Ecelbarger CM.
    Pharmacol Res; 2008 May 15; 57(5):383-92. PubMed ID: 18468451
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone.
    Khan O, Riazi S, Hu X, Song J, Wade JB, Ecelbarger CA.
    Am J Physiol Renal Physiol; 2005 Aug 15; 289(2):F442-50. PubMed ID: 15814531
    [Abstract] [Full Text] [Related]

  • 6. PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules.
    Fu Y, Gerasimova M, Batz F, Kuczkowski A, Alam Y, Sanders PW, Ronzaud C, Hummler E, Vallon V.
    Nephron; 2015 Aug 15; 129(1):68-74. PubMed ID: 25531136
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
    Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T.
    Proc Natl Acad Sci U S A; 2005 Jun 28; 102(26):9406-11. PubMed ID: 15956187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
    Borsting E, Cheng VP, Glass CK, Vallon V, Cunard R.
    Am J Physiol Renal Physiol; 2012 Mar 01; 302(5):F540-51. PubMed ID: 22169011
    [Abstract] [Full Text] [Related]

  • 11. Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus.
    Goenka N, Kotonya C, Penney MD, Randeva HS, O'Hare JP.
    Am J Physiol Endocrinol Metab; 2008 Apr 01; 294(4):E733-9. PubMed ID: 18230694
    [Abstract] [Full Text] [Related]

  • 12. mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite.
    Jia Z, Aoyagi T, Kohan DE, Yang T.
    Am J Physiol Renal Physiol; 2010 Jul 01; 299(1):F155-66. PubMed ID: 20335314
    [Abstract] [Full Text] [Related]

  • 13. Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats.
    Chen L, LaRocque LM, Efe O, Wang J, Sands JM, Klein JD.
    Am J Med Sci; 2016 Nov 01; 352(5):517-523. PubMed ID: 27865300
    [Abstract] [Full Text] [Related]

  • 14. Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
    Goltsman I, Khoury EE, Aronson D, Nativ O, Feuerstein GZ, Winaver J, Abassi Z.
    J Cell Mol Med; 2019 Jul 01; 23(7):4779-4794. PubMed ID: 31087547
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    Magenta G, Borenstein X, Rolando R, Jasnis MA.
    BMC Cancer; 2008 Feb 08; 8():47. PubMed ID: 18261208
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.